Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Slick Videos Won’t Save Lawful Access: Why The Government’s Bill C-22 Defence Avoids the Charter, Privacy and Security Concerns Raised By Critics 
The Law Bytes Podcast, Episode 268: Sara Grimes on the Moral Panic Behind Banning Kids from Social Media and AI Chatbots 
U.S. Congressional Leaders Warn Canadian Lawful Access Plans Harm U.S. National Security and Economic Interests 
Make It Make Sense: My Appearance Before the Standing Committee on Public Safety and National Security on Bill C-22’s Lawful Access Plan 
Why Social Media and AI Chatbot Bans for Kids Are Bad Policy: Making the Case at the Senate Social Affairs, Science and Tech Committee
